PMID- 21243279 OWN - NLM STAT- MEDLINE DCOM- 20111014 LR - 20220629 IS - 1980-5322 (Electronic) IS - 1807-5932 (Print) IS - 1807-5932 (Linking) VI - 65 IP - 11 DP - 2010 TI - Does minor histocompatibility antigen HA-1 disparity affect the occurrence of graft-versus-host disease in tunisian recipients of hematopoietic stem cells? PG - 1099-103 AB - INTRODUCTION: Minor histocompatibility antigen HA-1 (MiHAg-HA-1) disparity between a patient and his or her human leukocyte antigen (HLA) genoidentical donor has been widely associated with an increased risk of graft-versus-host disease following allogeneic hematopoietic stem cell transplantation. OBJECTIVE: To examine the effect of HA-1 disparity on the incidence of both acute and chronic graft-versus-host disease in Tunisian recipients of hematopoietic stem cells. METHODS: A total of 60 patients and their 60 respective sibling hematopoietic stem cell donors were enrolled in this study. All patients prophylactically received cyclosporine A and/or methotrexate for graft-versus-host disease. An HA-1 genotyping assay was performed with the SSP-PCR method, and HLA-A*0201- and/or HLA-A*0206-positive samples were identified using the Luminex HLA typing method. RESULTS: The Luminex HLA typing assay showed that 54 patients were positive for either the HLA-A*0201 or HLA-A*0206 alleles. Among these cases, six pairs were mismatched for MiHAg-HA-1. Both acute and chronic graft-versus-host disease occurred in four mismatched patients (Fisher's p-values were 0.044 and 0.170, respectively). A univariate logistic regression model analysis showed that only acute graft-versus-host disease may be affected by recipient MiHAg-HA-1 disparity (p: 0.041, OR: 6.727), while chronic graft-versus-host disease correlates with both age and recipient/donor sex mismatch (p: 0.014, OR: 8.556 and p: 0.033, OR: 8.664, respectively). CONCLUSION: Our findings support previously reported data suggesting a significant association between HA-1 disparity and the risk of acute graft-versus-host disease following hematopoietic stem cell transplantation. FAU - Sellami, Mohamed Hichem AU - Sellami MH AD - HLA-Typing Department, National Blood Transfusion Centre of Tunis, Tunisia. FAU - Torjemane, Lamia AU - Torjemane L FAU - Arias, Alejandro Espadas de AU - Arias AE FAU - Kaabi, Houda AU - Kaabi H FAU - Ladeb, Saloua AU - Ladeb S FAU - Poli, Francesca AU - Poli F FAU - Othmane, Tarek Ben AU - Othmane TB FAU - Hmida, Slama AU - Hmida S LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Clinics (Sao Paulo) JT - Clinics (Sao Paulo, Brazil) JID - 101244734 RN - 0 (HA-1 antigen) RN - 0 (HLA Antigens) RN - 0 (Minor Histocompatibility Antigens) RN - 0 (Oligopeptides) SB - IM MH - Adolescent MH - Adult MH - Alleles MH - Child MH - Child, Preschool MH - Female MH - Graft vs Host Disease/*immunology MH - HLA Antigens/*immunology MH - *Hematopoietic Stem Cell Transplantation MH - Histocompatibility Testing MH - Humans MH - Logistic Models MH - Male MH - Middle Aged MH - Minor Histocompatibility Antigens/genetics/*immunology MH - Oligopeptides/genetics/*immunology MH - Polymerase Chain Reaction MH - Risk Factors MH - Sex Factors MH - Tunisia MH - Young Adult PMC - PMC2999702 EDAT- 2011/01/19 06:00 MHDA- 2011/10/15 06:00 PMCR- 2010/11/01 CRDT- 2011/01/19 06:00 PHST- 2010/07/02 00:00 [received] PHST- 2010/07/26 00:00 [accepted] PHST- 2011/01/19 06:00 [entrez] PHST- 2011/01/19 06:00 [pubmed] PHST- 2011/10/15 06:00 [medline] PHST- 2010/11/01 00:00 [pmc-release] AID - S1807-5932(22)02891-5 [pii] AID - cln_65p1099 [pii] AID - 10.1590/s1807-59322010001100007 [doi] PST - ppublish SO - Clinics (Sao Paulo). 2010;65(11):1099-103. doi: 10.1590/s1807-59322010001100007.